ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Public Health Service: Blumenthal Declines White House Job

November 14, 1997

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

In Brief: ICC Had Only Planning, Not Core Support Grant; Number Of Ro1s In ’79 Understated

June 23, 1978

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

August 30, 2013